id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-328090-bprnq9wx	Abdollahimajd, Fahimeh	Novel coronavirus 2019 (COVID‐19) and epidermolysis bullosa: report of three cases	2020-08-14		.txt	text/plain	570	53	44	Epidermolysis bullosa (EB) is a skin fragility disorder caused by mutations in genes expressed in the cutaneous basement membrane zone 2, 3 . While an International consensus panel recently provided recommendations for prevention and multidisciplinary care of EB patients during the COVID-19 pandemic 4 , the phenotypic outcome in these patients in comparison to the general population has not been reported; however EB patients, particularly those with syndromic forms, may be at higher risk for infection with severe complications 4, 5 . Thus, the severity of the COVID-19 in these EB patients was in the spectrum experienced by the general population. Phenotypic spectrum of epidermolysis bullosa: The paradigm of syndromic versus non-syndromic skin fragility disorders Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic -Consensus: Recommendations by an international panel of experts Epidermolysis bullosa and the COVID-19 pandemic: challenges and recommendations	./cache/cord-328090-bprnq9wx.txt	./txt/cord-328090-bprnq9wx.txt